In lymph-node-positive tumors, we found members of the CARM1 and regulation of the ER pathway (CARM_ER) to be enriched, potentially indicating an involvement of chromatin-remodeling factors in breast cancer progression and metastasis (Wang et al., 2014). Here, CARM1 is linked to breast carcinoma.